Lu CH - Search Results

1

Inhibition of BAG3 enhances the anticancer effect of shikonin in hepatocellular carcinoma.

Lu J, Liu SY, Zhang J, Yang GM, Gao GB, Yu NN, Li YP, Li YX, Ma ZQ, Wang Y, Lu CH. Lu J, et al. Among authors: lu ch. Am J Cancer Res. 2021 Jul 15;11(7):3575-3593. eCollection 2021. Am J Cancer Res. 2021. PMID: 34354861 Free PMC article.

2

[Preparation of rabbit polyclonal antibodies against human copine-8 protein].

Zhang Z, Li Y, You J, Peng J, Lu J, Lu C. Zhang Z, et al. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2018 May;34(5):456-461. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2018. PMID: 30043736 Chinese.

3

Hsa-miR-335 enhances cell migration and invasion in lung adenocarcinoma through targeting Copine-1.

Wang Y, Zhang J, Zhong LY, Huang SJ, Yu NN, Ouyang L, Niu YL, Chen JX, Lu CH, He QY. Wang Y, et al. Among authors: lu ch. MedComm (2020). 2021 Nov 4;2(4):810-820. doi: 10.1002/mco2.93. eCollection 2021 Dec. MedComm (2020). 2021. PMID: 34977878 Free PMC article.

4

Pirin Promotes the Progression of Non-Small-Cell Lung Cancer by Increasing ODC1 to Suppress Autophagy.

Li YP, Huang ZJ, He QK, Li YX, Zhao XP, Ma ZQ, Qin MJ, Chen AW, Wei Q, Wang Y, Lu CH. Li YP, et al. Among authors: lu ch. J Proteome Res. 2024 May 3;23(5):1713-1724. doi: 10.1021/acs.jproteome.3c00871. Epub 2024 Apr 22. J Proteome Res. 2024. PMID: 38648079

5

MicroRNA-214-3p inhibits proliferation and cell cycle progression by targeting MELK in hepatocellular carcinoma and correlates cancer prognosis.

Li Y, Li Y, Chen Y, Xie Q, Dong N, Gao Y, Deng H, Lu C, Wang S. Li Y, et al. Cancer Cell Int. 2017 Nov 7;17:102. doi: 10.1186/s12935-017-0471-1. eCollection 2017. Cancer Cell Int. 2017. PMID: 29151817 Free PMC article.

6

Correction to: MicroRNA-214-3p inhibits proliferation and cell cycle progression by targeting MELK in hepatocellular carcinoma and correlates cancer prognosis.

Li Y, Li Y, Chen Y, Xie Q, Dong N, Gao Y, Deng H, Lu C, Wang S. Li Y, et al. Cancer Cell Int. 2018 Apr 10;18:55. doi: 10.1186/s12935-018-0556-5. eCollection 2018. Cancer Cell Int. 2018. PMID: 29652412 Free PMC article.

7

Quantitative phosphoproteomics of proteasome inhibition in multiple myeloma cells.

Ge F, Xiao CL, Bi LJ, Tao SC, Xiong S, Yin XF, Li LP, Lu CH, Jia HT, He QY. Ge F, et al. Among authors: lu ch. PLoS One. 2010 Sep 29;5(9):e13095. doi: 10.1371/journal.pone.0013095. PLoS One. 2010. PMID: 20927383 Free PMC article.

8

Transcriptomic and proteomic approach to studying SNX-2112-induced K562 cells apoptosis and anti-leukemia activity in K562-NOD/SCID mice.

Jin L, Xiao CL, Lu CH, Xia M, Xing GW, Xiong S, Liu QY, Liu H, Li YC, Ge F, Wang QD, He QY, Wang YF. Jin L, et al. Among authors: lu ch. FEBS Lett. 2009 Jun 18;583(12):1859-66. doi: 10.1016/j.febslet.2009.04.046. Epub 2009 May 8. FEBS Lett. 2009. PMID: 19427857 Free article.

9

Proteomics of apoptosis of multiple myeloma cells induced by proteasome inhibitor PS-341.

Jia H, Ge F, Lu X, Zeng H, Li L, Chen Z, Lu C. Jia H, et al. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2010 Aug;35(8):784-91. doi: 10.3969/j.issn.1672-7347.2010.08.003. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2010. PMID: 20818069

10

Subcellular proteomics revealed the epithelial-mesenchymal transition phenotype in lung cancer.

Li LP, Lu CH, Chen ZP, Ge F, Wang T, Wang W, Xiao CL, Yin XF, Liu L, He JX, He QY. Li LP, et al. Among authors: lu ch. Proteomics. 2011 Feb;11(3):429-39. doi: 10.1002/pmic.200900819. Epub 2011 Jan 3. Proteomics. 2011. PMID: 21268272

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,633 results

Search Page

Filters